Eisai
4523.T
#2232
Rank
โ‚น740.68 B
Marketcap
โ‚น2,625
Share price
-2.25%
Change (1 day)
11.14%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น78.30. an increase over its 2024 EPS that were of โ‚น88.27.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น98.7311.85%
2024โ‚น88.27-32.63%
2023โ‚น131.035.52%
2022โ‚น124.17-74.01%
2021โ‚น477.72-66.58%
2020โ‚น1,42998.24%
2019โ‚น720.9517.01%
2018โ‚น616.1437.78%
2017โ‚น447.20-27.62%
2016โ‚น617.8735.33%
2015โ‚น456.57-2.82%
2014โ‚น469.83-27.66%
2013โ‚น649.51-27.49%
2012โ‚น895.79-12.67%
2011โ‚น1,02688.08%
2010โ‚น545.41-11.06%
2009โ‚น613.25-390.15%
2008-โ‚น211.36-127.78%
2007โ‚น760.9311.78%
2006โ‚น680.754.38%
2005โ‚น652.217.4%
2004โ‚น607.3043.03%
2003โ‚น424.6125.09%
2002โ‚น339.4352.67%
2001โ‚น222.3369.76%
2000โ‚น130.97